Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

FCA slaps former star stock picker Neil Woodford and fund with £46m fine

(Sharecast News) - The Financial Conduct Authority said on Tuesday that it has fined former star stock picker Neil Woodford and Woodford Investment Management for failures in management of the Woodford Equity Income Fund (WEIF). The FCA has fined Woodford just under £5.9m and banned him from holding senior manager roles and managing funds for retail investors. WIM has been fined £40m.

The fund was suspended in June 2019, leaving investors - most of them ordinary retail customers - unable to access their money.

The value of the WEIF had fallen from more than £10.1bn in May 2017 to just £3.6bn in the run-up to its suspension.

The FCA concluded that between July 2018 and June 2019 WIM and Neil Woodford made "unreasonable and inappropriate" investment decisions. They disproportionately sold more liquid investments - those that are easier to sell - and bought fewer liquid ones.

This meant that at the time of suspension only 8% of the investments held by WEIF could be sold within seven days. Under rules in place at the time, investors should have been able to access their funds within four days.

Steve Smart, joint executive director of enforcement and market oversight at the FCA, said: "Being a leader in financial services comes with responsibilities as well as profile. Mr Woodford simply doesn't accept he had any role in managing the liquidity of the fund.

"The very minimum investors should expect is those managing their money make sensible decisions and take their senior role seriously. Neither Neil Woodford nor Woodford Investment Management did so, putting at risk the money people had entrusted them with."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.